Eli Lilly (NY: LLY )
584.04 -7.00 (-1.18%) Official Closing Price Updated: 7:00 PM EST, Dec 1, 2023 Add to My Watchlist
Press Releases about Eli Lilly
Darryle D. Schoepp, Ph.D., Former Merck and Eli Lilly Executive, Joins Scientific Advisory Board of Akelos Inc., Biotechnology Company Developing Opioid Alternatives
February 01, 2023
NEW YORK, February 1, 2023 (Newswire.com) - Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti-hyperalgesic drug to treat chronic and neuropathic...
Watch for Continued Gains in Shares of Eli Lilly and Company (LLY)
September 28, 2022
Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?
November 16, 2022
Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.
Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies
November 14, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 14, 2022 – USA News Group – English actor, comedian and Monty Python alumnus Eric Idle credits early detection for his...
Akouos (NASDAQ: AKUS) Enters Into Agreement to be Acquired by Eli Lilly (NYSE: LLY) at Valuation Up to $610 Million
October 18, 2022
Akouos, Inc. (NASDAQ: AKUS) is engaged as a precision genetic medicine company, which is focused on the research and development
Via Spotlight Growth
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
August 18, 2022
Americans with diabetes have been relying on insulin injections to manage their illness for decades. Those injections can be painful, expensive and inconvenient. The daily invasive testing regimen adds...
Global Liposarcoma Treatment Market 2022 Business Strategies and Overview Report 2031 Taro Pharmaceuticals, Sandoz, Pfizer, Eli Lilly, Sanofi SA, Novartis AG
July 13, 2022
The intelligent report on the global Liposarcoma Treatment market provides deep analysis of the Liposarcoma Treatment industry segments including product type, application, special geographies and...
Topics Supply Chain
Exposures Supply Chain
Global PCSK9 Inhibitors Market |Key players are Amgen, Eli Lilly, Sanofi, Pfizer, Novartis, Roche, Merck, Alnylam, AstraZeneca, Affiris, BMS, Ionis Pharmaceuticals, Cyon Therapeutics, and Daiichi Sankyo.
July 06, 2022
Global PCSK9 Inhibitors Market |Key players are Amgen, Eli Lilly, Sanofi, Pfizer, Novartis, Roche, Merck, Alnylam, AstraZeneca, Affiris, BMS, Ionis Pharmaceuticals, Cyon Therapeutics, and Daiichi...
SWOT Analysis on Diabetes Devices Sales Market Revenue 2022-2029 : Medtronic, Sanofi, Novo Nordisk, Medtronic
July 01, 2022
Global Diabetes Devices Market Research 2022-2031 published by Calibre Research studies the current situation, Diabetes Devices market size, share, trends, regional growth and the latest technologies...
Topics Supply Chain
Exposures Supply Chain
Palm Beach, FL – June 7, 2022 – FinancialNewsMedia.com News Commentary – According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer’s, neonatal...
Palm Beach, FL – May 31, 2022 – FinancialNewsMedia.com News Commentary – Diabetes is a chronic health condition that occurs when your body’s blood glucose, also called blood sugar, is too high. Blood...
Pain Management Drugs Market Increased Research Activities Boost Demand Opportunities The global pain management drugs market was valued at $71,431.85 million in 2019, and is projected to reach...
Veterinary Antibiotics Market Research Insight 2022| Key Players are Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi S.A., Ve
May 17, 2022
Smart Insulin Pen Market Size 2022 SWOT Analysis by Key Players – Companion Medical, Digital Medics Ptd, Eli Lilly and Company, Novo Nordisk A/S, Diamesco Co.
March 22, 2022
Smart Insulin Pens s valued approximately USD 89.53 million in 2020 and is anticipated to grow with a healthy growth rate of more than 10.77% over the forecast period 2022-2028.